Clinical Presentations and Outcomes of Takotsubo Syndrome in the Setting of Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis
Overview
Affiliations
Background: Evidence remains inconsistent regarding the incidence and prognosis of Takotsubo syndrome in the setting of subarachnoid hemorrhage. Thus, we aimed to evaluate the clinical presentation and in-hospital mortality of these patients.
Methods: A systematic review of the electronic databases was conducted for studies involving patients with spontaneous subarachnoid hemorrhage and concomitant findings of classical Takotsubo syndrome on transthoracic echocardiogram. A meta-analysis was conducted for the primary outcome of in-hospital mortality using the Mantel-Haenszel method for fixed effects and the DerSimonian and Laird method for random effects, with 95% confidence interval and a p-value <0.05 for statistical significance.
Results: Ten studies were retrieved with a total of 157 patients presenting with classical Takotsubo syndrome, representing 4.4% of the subarachnoid hemorrhage total population. The overall incidence of in-hospital mortality was 30% in the patients who developed Takotsubo syndrome. Meta-analysis illustrated a significant increase in the odds of in-hospital mortality for the Takotsubo syndrome patients by fixed effects model (odds ratio 2.6, 95% confidence interval 1.16-5.85, p=0.02, I=39%), with a trend towards increased risk of in-hospital mortality by random effects model (odds ratio 3.00, 95% confidence interval 0.90-9.77, p = 0.07).
Conclusions: The incidence of Takotsubo syndrome in patients with spontaneous subarachnoid hemorrhage seems to be high with a trend towards higher risk of in-hospital mortality in those patients. Thus, patients presenting with subarachnoid hemorrhage might benefit from a comprehensive cardiac evaluation upon presentation for early detection and proper triage of this high-risk population.
Cardiac Findings Following Cerebrovascular Disease.
Rohner MD M, Gebhard C, Luft A, Hansel M, Wegener S J Am Heart Assoc. 2024; 13(17):e034131.
PMID: 39190586 PMC: 11646524. DOI: 10.1161/JAHA.124.034131.
Li S, Ding P, Wang C, Long K, Gao P Front Cardiovasc Med. 2024; 11:1383903.
PMID: 39108674 PMC: 11301645. DOI: 10.3389/fcvm.2024.1383903.
Szanto D, Luteran P, Gal J, Nagy E, Fulesdi B, Molnar C Rev Cardiovasc Med. 2024; 24(6):177.
PMID: 39077518 PMC: 11264119. DOI: 10.31083/j.rcm2406177.
Eter A, Yamamoto T, Koutrouvelis A, Yamamoto S Cureus. 2024; 16(6):e62533.
PMID: 39022462 PMC: 11253893. DOI: 10.7759/cureus.62533.
Zaman F, Isom N, Chang A, Wang Y, Abdelhamid A, Khan A Eur Heart J Digit Health. 2024; 5(2):134-143.
PMID: 38505490 PMC: 10944681. DOI: 10.1093/ehjdh/ztad077.